Transvaginal Mesh Dangers

latest_2

Transvaginal mesh was developed to repair pelvic damage to women who have suffered from stress urinary incontinence or pelvic organ prolapse. This mesh can be inserted with a minimally invasive procedure and is meant to patch or strengthen weakened or destroyed tissue.

However, thousands of women have experienced problems with the mesh, ranging from pain to organ damage. These injuries have included:

  • Bleeding from the mesh site
  • Damage to nearby organs
  • Erosion of the mesh
  • Infection
  • Pain, including pain during intercourse
  • Urinary tract problems, including continued or increased incontinence

Many manufacturers of the product have faced, or are currently facing, legal action for the damages sustained by patients. One of the most prominent companies facing these issues is the Avaulta Anterior and Posterior Biosynthetic Support System made by C. R. Bard Inc., with about 9,000 Bard transvaginal mesh lawsuits currently pending in consolidated federal multidistrict litigation.

The first company to release the mesh, Boston Scientific, issued a recall on its devices only a few years after its release in the 1990s. However, mass studies and action on the devices as only come to a head in the last few years. In 2012, the FDA ordered 33 makers of transvaginal mesh products to conduct testing on patient outcomes and report all complications stemming from the use of their products.

In July 2014, the FDA denied a ban on U.S. sales of transvaginal mesh products, despite a petition filed by Public Citizen’s Health Research Group asking for discontinued use and ban on the products. Currently, Derek Potts is serving in a leadership role in several multi-district litigation efforts to hold manufacturers responsible and protect women from the dangers of transvaginal mesh.

The Potts Law Firm is actively participating in many MDLs and claims regarding transvaginal mesh. If you or a loved one has been harmed as a result of transvaginal mesh from any manufacturer, contact The Potts Law Firm today to arrange your free consultation.

 

Hip Implant Recalls

latest_3

According to the CDC, over 300,000 patients received hip implants in 2010 in the U.S. Whether aging or an injury is to blame, the hip is an important joint in allowing mobility and every day functionality. The industry of hip implants includes many manufacturers who are constantly seeking ways to make the devices more effective in providing natural mobility to patients.

Unfortunately, some of these devices have proven to be a risk to patients rather than an aid. Companies facing recalls and lawsuits regarding defective hip implants include DePuy, Stryker, Biomet and Zimmer. The hazards associated with each device may vary, but some of the dangers include:

Dislocation – In the event that a device is worn down enough, it can dislocate within the body and become misaligned. In addition to excruciating pain, this causes the need for surgery to repair or replace the implant.

Metal Toxins – When the pieces of the hip implants move against each other within the body, the materials may start to break down over time. Even in extremely tiny flakes, the metals of the parts can enter the bloodstream and poison the patient. Cobalt, chromium, and other metals can cause both short and long-term effects on the body.

In addition, bone fractures can occur near the implants site, or the implant itself can become loosened within the body. Since the hip bears a large portion of the body’s weight when standing, even a slight issue can cause extreme pain and render a patient immobile until the implant can be repaired.

Due to these risks, many hip implants have been recalled and thousands of lawsuits have been filed. If you are not sure if the model of your implant has been recalled or you may have suffered due to a malfunctioning implant, the attorneys of The Potts Law Firm can provide a free consultation to discuss the details of your case with you.

  •                                            
                                   
  • '
  • Latest From Our Blog